Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Companion diagnostic testing for targeted cancer therapies: an overview.

Genetic testing and molecular biomarkers - 1 Jul 2013

Fan Yao-Shan

Abstract excerpt

Genes and their products involved in the biological pathways of human cancers have been studied as either targets of new therapies, or predictive markers for the sensitivity of or resistance to the therapies. Companion diagnostic testing on biological markers for targeted cancer therapies has become a vital component of personalized cancer treatment. This article provides an overview on the biological pathways...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Neoplasms

Share to Precision Medicine

Share to United States

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 23574530
DOI: 10.1089/gtmb.2012.0510

Genes

BRAF
KRAS
ALK
EGFR
KIT
ROS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Companion diagnostic testing for targeted cancer therapies: an overview.PMID 23574530Read ↗

Companion biomarkers: paving the pathway to personalized treatment for cancer.Semantic proximity Read ↗

Special report: multiple molecular testing of cancers to identify targeted therapies.Semantic proximity Read ↗

[Current update and testing procedures for genetic diagnosis in malignant neoplasm: additional information on pathological tests].Semantic proximity Read ↗

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.Semantic proximity Read ↗

Mutation detection and molecular targeted tumor therapiesSemantic proximity Read ↗

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.Semantic proximity Read ↗

Market watch: emerging companion diagnostics for cancer drugs.Semantic proximity Read ↗

Has discovery-based cancer research been a bust?Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

The Evolution of Oncology Companion Diagnostics from Signal Transduction to Immuno-OncologySemantic proximity Read ↗

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.Semantic proximity Read ↗

Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.